Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
PS278-05
print preview
bookmark
share with colleague
General Information
Company
Proteome Sciences plc
Description
Casein kinase 1 delta (CSNK1D; CKI-delta) inhibitor
Molecular Target
Casein kinase 1 delta (CSNK1D) (CKI-delta)
Mechanism of Action
Latest Stage of Development
Preclinical
Indication
Alzheimer's disease (AD)
Partner
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy